Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

India · Delayed Price · Currency is INR

208.90

-8.44 (-3.88%)

May 11, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Apr '17 Apr 1, 2017
Manufacturing and Trading of Pharmaceutical Products	2.87B	2.69B	2.09B	2.37B	2.18B
Manufacturing and Trading of Pharmaceutical Products Growth	6.89%	28.76%	-11.83%	8.79%	15.77%
Total	2.87B	2.69B	2.09B	2.37B	2.18B
Total Growth	6.89%	28.76%	-11.83%	8.79%	15.77%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Apr '17 Apr 1, 2017
India	2.65B	2.04B	2.31B	2.12B
India Growth	29.98%	-11.74%	8.97%	-
Rest of The World	34.96M	46.61M	55.28M	54.26M
Rest of The World Growth	-24.99%	-15.68%	1.88%	-
Total	2.69B	2.09B	2.37B	2.18B
Total Growth	28.76%	-11.83%	8.79%	-

Source: S&P Global Market Intelligence.